Company Filing History:
Years Active: 2001-2009
Title: The Innovative Contributions of David M Hollenback
Introduction
David M Hollenback is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. With a total of 7 patents to his name, Hollenback's work has the potential to impact medical science profoundly.
Latest Patents
One of Hollenback's latest patents is focused on LPAAT-β inhibitors and their uses. This invention relates to triazines and their application in inhibiting lysophosphatidic acid acyltransferase β (LPAAT-β) activity. The invention also outlines methods for treating cancer using these triazines, as well as methods for screening LPAAT-β activity. This innovative approach showcases Hollenback's commitment to advancing cancer therapies.
Career Highlights
Throughout his career, Hollenback has worked with various companies, including Cell Therapeutics, Inc. and Cell Therapeutics, Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of medical technologies.
Collaborations
Hollenback has collaborated with notable individuals in his field, including David W Leung and Daniel Adourel. These partnerships have likely enriched his work and expanded the scope of his innovations.
Conclusion
David M Hollenback's contributions to biotechnology and cancer treatment through his patents and collaborations highlight his role as a significant inventor in the field. His innovative work continues to pave the way for advancements in medical science.